Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (2): 187-188.DOI: 10.3969/j.issn.1673-8640.2019.02.022
Received:2018-09-06
Online:2019-02-28
Published:2019-02-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.02.022
| [1] | 高凌峰. 无偿献血者弱D鉴定两种试剂结果不一致分析与探讨[J]. 临床医药文献电子杂志,2017,4(38):7453. |
| [2] | 李岚,伍昌林,党鑫堂,等. Rh阴性血型筛查及不规则抗体检测的临床意义[J]. 中国生物制品学杂志,2011,24(5):594-595. |
| [3] | 王贞,贾双双,陈景旺,等. 弱D25变异型血型抗原表位分析及输血策略探讨[J]. 中国输血杂志,2018,31(3):234-237. |
| [4] | 吴娟. 卡式配血法常见原因分析及应对措施[J]. 检验医学与临床,2013,10(2):224-225. |
| [5] | 尚红,王毓三,申子瑜. 全国临床检验操作规程[M]. 4版. 北京:人民卫生出版社,2014:126. |
| [6] | JI Y L,VAN DER SCHOOT C E. Red blood cell genotyping in China[J]. ISBT Science Series,2016,11(Suppl 2):55-68. |
| [7] | FLEGEL W A,WANGNER F F.Molecular biology of partial D and weak D:implications for blood bank practice[J]. Clin Lab,2002,48(1-2):53-59. |
| [8] | AVENT N D,REID M E.The Rh blood group system:a review[J]. Blood,2000,95(2):375-387. |
| [9] | 丁琪,兰烔采. 红细胞输注所致免疫反应的研究进展[J]. 临床血液学杂志(输血与检验版),2007,4(6):283-285. |
| [10] | 马红丽,刘红冰,许秀荣. 输血前开展A2/A2B亚型和Rh弱D血型检测的临床意义[J]. 临床血液学杂志(输血与检验版),2011,24(6):707-708. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
